Thanks for attending 2004 Ready to Commercialize: Emerging Opportunities for Investors, Partners, and CXOs. The event brought together VCs, angels, corporate investors, CXOs, entrepreneurs and related professionals to review opportunities in software, wireless, nanomaterials, semiconductor, healthcare, automotive, and energy. In addition to the select technology presentations, speakers included Adam Heller, founder of TheraSense, a company based on University of Texas technology that was recently sold to Abbott Labs for $1.2 billion. The program also featured remarks from Texas Governor Rick Perry and University of Texas at Austin President Larry Faulkner. A series of panel sessions, including "Structuring a Deal with the University" and "Technology Initiatives for the State of Texas," were part of the overall program.
Download the entire Conference
Booklet (PDF, 1.8M)














8:30 |
Opening remarks
Neil Iscoe, Director, Office of Technology Commercialization
|
Panel
How to make technology deals work: a legal perspective
|
|
| 9:15 | Nanotech Center update
Steve Nichols, Associate VP for Research, The University of Texas at Austin |
Panel
Structuring a deal with the University
There are many ways to structure technology commercialization deals, such as licensing, corporate equity, convertible debt, and partnerships. Speakers will discuss successful deals with the university. Panelists include:
|
|
| 10:50 | Inventor presentations
|
Lunch and luncheon panel
Technology initiatives for the State of Texas
A panel of Texas business and policy leaders will discuss latest approaches to commercializing technology.
|
|
| 1:45 | Inventor presentations
|
| 2:45 | Speaker
The TheraSense Story
From UT technology to product; from company to IPO.
TheraSense was founded in 1996 by Adam and Ephraim Heller to develop and
market glucose monitoring devices. The company was recently acquired by
Abbott Labs for $1.2 billion. Adam Heller
will speak about the founding of TheraSense and its technology. |
| 3:30 | Inventor presentations
|
Concluding remarks
|
|
| 5:30 | Networking reception |
Copyright ©2006-2009, Office of Technology Commercialization. All rights reserved.